118 related articles for article (PubMed ID: 16689158)
1. Exploring options for expanded newborn screening.
Baily MA; Becker W; Hayes M; Clayton EW; Grosse S
J Law Med Ethics; 2005; 33(4 Suppl):46-8. PubMed ID: 16689158
[No Abstract] [Full Text] [Related]
2. [Mass Screening for Inborn Errors of Metabolism].
Ito T
Rinsho Byori; 2015 Apr; 63(4):441-9. PubMed ID: 26536777
[TBL] [Abstract][Full Text] [Related]
3. Incidence and short-term outcome of children with symptomatic presentation of organic acid and fatty acid oxidation disorders in Germany.
Klose DA; Kölker S; Heinrich B; Prietsch V; Mayatepek E; von Kries R; Hoffmann GF
Pediatrics; 2002 Dec; 110(6):1204-11. PubMed ID: 12456920
[TBL] [Abstract][Full Text] [Related]
4. Exercise testing in metabolic myopathies.
Tarnopolsky M
Phys Med Rehabil Clin N Am; 2012 Feb; 23(1):173-86, xii. PubMed ID: 22239882
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
Diekman EF; Ferdinandusse S; van der Pol L; Waterham HR; Ruiter JP; Ijlst L; Wanders RJ; Houten SM; Wijburg FA; Blank AC; Asselbergs FW; Houtkooper RH; Visser G
Genet Med; 2015 Dec; 17(12):989-94. PubMed ID: 25834949
[TBL] [Abstract][Full Text] [Related]
6. New fatty acid oxidation inhibitors with increased potency lacking adverse metabolic and electrophysiological properties.
Koltun DO; Marquart TA; Shenk KD; Elzein E; Li Y; Nguyen M; Kerwar S; Zeng D; Chu N; Soohoo D; Hao J; Maydanik VY; Lustig DA; Ng KJ; Fraser H; Zablocki JA
Bioorg Med Chem Lett; 2004 Jan; 14(2):549-52. PubMed ID: 14698201
[TBL] [Abstract][Full Text] [Related]
7. The structure of the multienzyme complex of fatty acid oxidation from Escherichia coli.
Pawar S; Schulz H
J Biol Chem; 1981 Apr; 256(8):3894-9. PubMed ID: 7012144
[No Abstract] [Full Text] [Related]
8. Glutamate 139 of the large alpha-subunit is the catalytic base in the dehydration of both D- and L-3-hydroxyacyl-coenzyme A but not in the isomerization of delta 3, delta 2-enoyl-coenzyme A catalyzed by the multienzyme complex of fatty acid oxidation from Escherichia coli.
Yang SY; He XY; Schulz H
Biochemistry; 1995 May; 34(19):6441-7. PubMed ID: 7756275
[TBL] [Abstract][Full Text] [Related]
9. Management of fatty acid oxidation disorders: a survey of current treatment strategies.
Solis JO; Singh RH
J Am Diet Assoc; 2002 Dec; 102(12):1800-3. PubMed ID: 12487544
[TBL] [Abstract][Full Text] [Related]
10. Histidine-450 is the catalytic residue of L-3-hydroxyacyl coenzyme A dehydrogenase associated with the large alpha-subunit of the multienzyme complex of fatty acid oxidation from Escherichia coli.
He XY; Yang SY
Biochemistry; 1996 Jul; 35(29):9625-30. PubMed ID: 8755745
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the fatty acid oxidation complex in acetyl-CoA-dependent chain elongation of fatty acids in Escherichia coli.
Nishimaki-Mogami T; Yamanaka H; Mizugaki M
J Biochem; 1987 Aug; 102(2):427-32. PubMed ID: 3312186
[TBL] [Abstract][Full Text] [Related]
12. [Acute fatty liver of pregnancy and mitochondrial fatty acid oxidation. Consequences for the offspring].
Anon B; Barbet C; Gendrot C; Labarthe F; Bacq Y
Arch Pediatr; 2017 Aug; 24(8):777-782. PubMed ID: 28647472
[TBL] [Abstract][Full Text] [Related]
13. Multienzyme complexes of fatty acid oxidation from Escherichia coli K12 and from a mutant with a defective L-3-hydroxyacyl coenzyme A dehydrogenase.
Pramanik A; Schulz H
Biochim Biophys Acta; 1983 Jan; 750(1):41-6. PubMed ID: 6402028
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
[TBL] [Abstract][Full Text] [Related]
15. Structure of mycobacterial β-oxidation trifunctional enzyme reveals its altered assembly and putative substrate channeling pathway.
Venkatesan R; Wierenga RK
ACS Chem Biol; 2013 May; 8(5):1063-73. PubMed ID: 23496842
[TBL] [Abstract][Full Text] [Related]
16. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha.
Gerhart-Hines Z; Rodgers JT; Bare O; Lerin C; Kim SH; Mostoslavsky R; Alt FW; Wu Z; Puigserver P
EMBO J; 2007 Apr; 26(7):1913-23. PubMed ID: 17347648
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for channelling mechanism of a fatty acid beta-oxidation multienzyme complex.
Ishikawa M; Tsuchiya D; Oyama T; Tsunaka Y; Morikawa K
EMBO J; 2004 Jul; 23(14):2745-54. PubMed ID: 15229654
[TBL] [Abstract][Full Text] [Related]
18. Effect of high-intensity intermittent swimming training on fatty acid oxidation enzyme activity in rat skeletal muscle.
Terada S; Tabata I; Higuchi M
Jpn J Physiol; 2004 Feb; 54(1):47-52. PubMed ID: 15040848
[TBL] [Abstract][Full Text] [Related]
19. beta-Oxidation enzymes in fibroblasts from patients with 3-hydroxydicarboxylic aciduria.
Venizelos N; Ijlst L; Wanders RJ; Hagenfeldt L
Pediatr Res; 1994 Jul; 36(1 Pt 1):111-4. PubMed ID: 7936829
[TBL] [Abstract][Full Text] [Related]
20. Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation.
Shen S; Faouzi S; Souquere S; Roy S; Routier E; Libenciuc C; André F; Pierron G; Scoazec JY; Robert C
Cell Rep; 2020 Nov; 33(8):108421. PubMed ID: 33238129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
